Navigation Links
Perrigo Company Announces Dividend Increase
Date:10/30/2007

ALLEGAN, Mich., Oct 30 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.05 per share, payable on December 18, 2007 to shareholders of record on November 23, 2007. The new quarterly dividend of $0.05 per share represents an eleven percent increase over $0.045 per share paid in the last four quarters.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum
2. Medicis Pharmaceutical company enters pediatric market
3. Problems Of a Growing Company
4. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
5. British company developing ‘Safer Cigarettes
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Elderly People Prefer The Company Of Pet Dogs
8. Ossur Acquires the U.S. Orthopaedics Company
9. Britain Approves Indian Company For Supplying Medicines
10. Drug Company Admits Knowledge Of Side Effects In Monkeys
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...wire/ -- Harrington Physician Services (HPS) is pl...physicians Martin Devine, Leah Doret, Elizabeth Fu... ,, These four esteemed and popular Charlton-ba...l soon join the Harrington family in the new Harri...ng under construction at 10 North Main Street, at ...
(Date:11/30/2009)...e registration of a visual stimulus by the unconsc...13; between the time we see an apple and the time ...our eyes, but by how long? And how does this affec... estimates say the time delay lasts only 100 milli...by Tel Aviv University psychologists says that the...
(Date:11/30/2009)...lly designed program, study finds , , MO...sive early intervention program for toddlers with ...n,s language and social skills, a new study shows....e able to learn and make remarkable progress," sai...ished online Nov. 30 in Pediatrics , and chief s...
(Date:11/30/2009)... 30 Sunlamps and tannin..., but the ultraviolet (UV) radiation from these de...ttp://www.newscom.com/cgi-bin/prnh/20090824/FDALOG...gives them a ,healthy, glow, any tan is a sign of ... and Drug Administration (FDA) scientist and inter...
(Date:11/30/2009)...- Physicians at Beth Israel Deaconess Medical Cent...emonstrating the potential for automated analysis ...Analyzer System® to assist in rapidly ruling ... department (ED ) patients with chest pain. The ab...f cCTA has potential to significantly reduce unnec...
Breaking Medicine News(10 mins):Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:Now you see it, now you know you see it 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3
...rt Day, Home Care Delivered reinforces the benefit...o help patients with diabetes better manage their ... Home Care Delivered, Inc., a leading mail-order p...erican Diabetes Alert Day. American Diabetes Alert...
...ancer-promoting genes, a process known as hypermet...s by disrupting biological brakes on runaway growt...process demethylation which wipes off those chem...eat some cancers may actually cause new cancers as...
...nd midwives have visually examined newborn babies ..., judging that more extensive jaundice carried a g...om a blood byproduct, bilirubin, and a child that ...ng practice of visual inspection is an unreliable ...
...lable for Florida Providers , , JACKSONVILLE, ...ier health information network, announced today an..., a national leader in providing affordable health...eb portal for the transmission of real-time eligib...
...s, makers of the ReBound(TM) Therapeutic Warming S...) diathermy, today announced that it has closed a ...estment by Stonewood Capital Management, Inc. , ,...tors and close out the round with an investor as r...
...chigan University School of Nursing has received ...Energy, Labor & Economic Growth (DELEG) and Co... Michigan Nurse Corps (MNC) program, this grant wi...vides educational stipends and tuition to graduate...
Other Medicine News:Health News:Home Care Delivered, Inc. Recognizes 21st Annual American Diabetes Alert Day 2Health News:Genetic changes outside nuclear DNA suspected to trigger more than half of all cancers 2Health News:Don't rely on jaundiced eye for assessing newborns 2Health News:Don't rely on jaundiced eye for assessing newborns 3Health News:Availity Expands Partnership with Molina Healthcare 2Health News:ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc. 2Health News:EMU Receives $634,000 Grant From State to Help Stem Nursing Shortage 2
(Date:11/30/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Decubitus Ulcer Treatment Products -...rtlinker.com/p0164283/Decubitus-Ulcer-Treatment-Pr...cubitus Ulcers are lesions resulting from tissue d... bodyweight. Pressure ulcer treatment products var...
(Date:11/30/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Inflammatory Disorders: Therapies Tha...http://www.reportlinker.com/p0165600/Inflammatory-...mmune-Response.html ,, The human immune system...or producing an exaggerated response to a foreign ...
(Date:11/30/2009)...ov. 30 eHealthSource.com launched ...ly to products approved for Flexible Spending Acco...he site is also the first to exclusively carry val...ppers up to 75 percent on everyday healthcare need...lthcare headaches - high costs and complexity," sa...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Media Advisory Oncolytics Biotech Inc to Present at BIO Investor Forum 2009 14580 1Media Advisory Oncolytics Biotech Inc to Present at BIO Investor Forum 2009 14580 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4
...pril 2 Micromet, Inc. (Nasdaq: MITI ), a biopha...antibodies for the treatment of cancer, inflammati...ling of the first clinical trial application (CTA)...CSF antibody MT203. Micromet received a payment of...or the achievement of this milestone. , , Under a...
... Responding to President Obama,s call for "a cure ...ch and Manufacturers of America (PhRMA) delivered ...peline for cancer. The report shows that America,s...es are testing a record 861 new cancer medicines a...e being tested in human clinical trials or are awa...
Other Medicine Technology:Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203 2Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203 3Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203 4New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 2New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 3New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer 4
McPherson Speculum
Storz Twisted Snare Wire
Thorton Fixation Ring 16 mm
McNeil-Goldman Scleral and Blepharostat Ring
Medicine Products: